Cargando…
Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
OBJECTIVE: To evaluate the incidence of benign prostatic hyperplasia (BPH) and metabolic syndrome in patients with androgenetic alopecia (AGA) in comparison with those with no AGA, as several previous studies have reported inconsistent results of an association between metabolic syndrome and BPH wit...
Autores principales: | Agamia, Naglaa F., Abou Youssif, Tamer, El-Hadidy, Abeer, El-Abd, Amr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963145/ https://www.ncbi.nlm.nih.gov/pubmed/27489744 http://dx.doi.org/10.1016/j.aju.2016.01.003 |
Ejemplares similares
-
Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020) -
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019
por: Xu, Xiao-Feng, et al.
Publicado: (2021) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Treatment: A Russian Multicenter Study in More Than 1,000 Treated
Patients
por: Kamalov, Armais, et al.
Publicado: (2020) -
The Efficacy and Safety of HoLEP for Benign Prostatic Hyperplasia With Large Volume: A Systematic Review and Meta-Analysis
por: Sun, Fengze, et al.
Publicado: (2022) -
Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019)